Futureco Bioscience and Sumitomo Corporation have signed global agreement to advance new, high-performance biological crop protection technology.

The global evaluation with licensing option agreement concerns a proprietary biological crop protection technology, developed and patented by Futureco Bioscience, which is currently undergoing registration in both Europe and the United States.

At the core of this agreement is a novel biocontrol product, based on the proprietary strain B2017 of Pseudomonas alloputida. Futureco says this biological solution has demonstrated consistent and robust efficacy in both internal studies and independently conducted field trials. It provides broad-spectrum control against key fungal and bacterial pathogens, including powdery mildew, downy mildew, Botrytis spp., Pseudomonas syringae, and Xanthomonas spp.

The product is protected under international patents and is advancing through regulatory processes in key agricultural markets.